Logo image of RGC

REGENCELL BIOSCIENCE HOLDING (RGC) Stock Price, Quote, News and Overview

NASDAQ:RGC - Nasdaq - KYG7487R1002 - Common Stock - Currency: USD

4.5  +0.4 (+9.76%)

After market: 4.19 -0.31 (-6.89%)

RGC Quote, Performance and Key Statistics

REGENCELL BIOSCIENCE HOLDING

NASDAQ:RGC (2/21/2025, 8:00:01 PM)

After market: 4.19 -0.31 (-6.89%)

4.5

+0.4 (+9.76%)

Sector
GICS SectorHealth Care
GICS IndustryPharmaceuticals
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS SubIndustryPharmaceuticals
Statistics
52 Week High32.44
52 Week Low3.03
Market Cap58.55M
Shares13.01M
Float1.46M
Yearly DividendN/A
Dividend YieldN/A
PEN/A
Fwd PEN/A
Earnings (Next)12-13 2022-12-13/bmo
IPO07-16 2021-07-16


RGC short term performance overview.The bars show the price performance of RGC in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 20 -20 -40

RGC long term performance overview.The bars show the price performance of RGC in the last 1, 2 and 3 years. 1 year 2 years 3 years -20 -40 -60 -80

The current stock price of RGC is 4.5 USD. In the past month the price decreased by -5.66%. In the past year, price decreased by -40.55%.

REGENCELL BIOSCIENCE HOLDING / RGC Daily stock chart

RGC Competitors/Peers

The largest stocks on the US markets in the "Pharmaceuticals" sub-industry
Full List
Symbol
Name
TA
FA
PE
Market Cap
LLY ELI LILLY & CO 67.21 829.40B
NVO NOVO-NORDISK A/S-SPONS ADR 27.53 390.99B
JNJ JOHNSON & JOHNSON 16.25 390.76B
AZN ASTRAZENECA PLC-SPONS ADR 20.56 230.17B
MRK MERCK & CO. INC. 11.71 226.40B
NVS NOVARTIS AG-SPONSORED ADR 13.77 215.98B
PFE PFIZER INC 8.46 149.04B
SNY SANOFI-ADR 13.62 136.54B
BMY BRISTOL-MYERS SQUIBB CO 48.97 113.23B
GSK GSK PLC-SPON ADR 7.81 74.77B
ZTS ZOETIS INC 27.1 72.39B
TAK TAKEDA PHARMACEUTIC-SP ADR 31.95 44.58B

About RGC

Company Profile

RGC logo image Regencell Bioscience Holdings Ltd. engages in the research, development, and commercialization of traditional Chinese medicine. The company employs 12 full-time employees The company went IPO on 2021-07-16. The firm launches three liquid based standardized TCM formulae candidates for mild, moderate and severe ADHD and ASD patients.

Company Info

REGENCELL BIOSCIENCE HOLDING

11/F, First Commercial Building, 33-35 Leighton Road, Causeway Bay

Hong Kong 37918 HK

CEO: Yat-Gai Au

Employees: 12

Company Website: https://www.regencellbioscience.com/

Investor Relations: http://www.regencellbioscience.com/investor-relations/

Phone: 85221550823

REGENCELL BIOSCIENCE HOLDING / RGC FAQ

What is the stock price of REGENCELL BIOSCIENCE HOLDING today?

The current stock price of RGC is 4.5 USD. The price increased by 9.76% in the last trading session.


What is the ticker symbol for REGENCELL BIOSCIENCE HOLDING stock?

The exchange symbol of REGENCELL BIOSCIENCE HOLDING is RGC and it is listed on the Nasdaq exchange.


On which exchange is RGC stock listed?

RGC stock is listed on the Nasdaq exchange.


What is REGENCELL BIOSCIENCE HOLDING worth?

REGENCELL BIOSCIENCE HOLDING (RGC) has a market capitalization of 58.55M USD. This makes RGC a Micro Cap stock.


How many employees does REGENCELL BIOSCIENCE HOLDING have?

REGENCELL BIOSCIENCE HOLDING (RGC) currently has 12 employees.


What are the support and resistance levels for REGENCELL BIOSCIENCE HOLDING (RGC) stock?

REGENCELL BIOSCIENCE HOLDING (RGC) has a support level at 3.59 and a resistance level at 6.65. Check the full technical report for a detailed analysis of RGC support and resistance levels.


Should I buy REGENCELL BIOSCIENCE HOLDING (RGC) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:


Does REGENCELL BIOSCIENCE HOLDING (RGC) stock pay dividends?

RGC does not pay a dividend.


When does REGENCELL BIOSCIENCE HOLDING (RGC) report earnings?

REGENCELL BIOSCIENCE HOLDING (RGC) will report earnings on 2022-12-13, before the market open.


What is the Price/Earnings (PE) ratio of REGENCELL BIOSCIENCE HOLDING (RGC)?

REGENCELL BIOSCIENCE HOLDING (RGC) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.59).


What is the Short Interest ratio of REGENCELL BIOSCIENCE HOLDING (RGC) stock?

The outstanding short interest for REGENCELL BIOSCIENCE HOLDING (RGC) is 1.49% of its float. Check the ownership tab for more information on the RGC short interest.


RGC Technical Analysis


Chartmill TA Rating
Chartmill Setup Rating

RGC Fundamental Analysis

ChartMill assigns a fundamental rating of 3 / 10 to RGC. While RGC has a great health rating, there are worries on its profitability.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

RGC Financial Highlights

Over the last trailing twelve months RGC reported a non-GAAP Earnings per Share(EPS) of -0.59. The EPS decreased by -321.43% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA -58.95%
ROE -61.85%
Debt/Equity 0
Chartmill High Growth Momentum
EPS Q2Q%-172.73%
Sales Q2Q%N/A
EPS 1Y (TTM)-321.43%
Revenue 1Y (TTM)N/A

RGC Ownership and Analysts

ChartMill assigns a Buy % Consensus number of 63% to RGC. The Buy consensus is the average rating of analysts ratings from 12 analysts.


Ownership
Inst Owners0.29%
Ins Owners81.22%
Short Float %1.49%
Short Ratio0.9
Analysts
Analysts63.4
Price TargetN/A
EPS Next YN/A
Revenue Next YearN/A